What Is the Future of Factor XI Inhibitors?
Jeffrey I. Weitz, John W. Eikelboom
Abstract
arenteral and oral factor XI (FXI) inhibitors, the next potential generation of anticoagulants, are undergoing phase-3 evaluation with the hope that they will be safer than currently available agents.
Topics & Concepts
MedicinePopulationLibrary scienceFamily medicineComputer scienceEnvironmental healthCoagulation, Bradykinin, Polyphosphates, and AngioedemaBlood Coagulation and Thrombosis MechanismsUrticaria and Related Conditions